301301 川宁生物
2026/03 -
人民币(K¥)
与去年末期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)

非流动资产
长期股权投资181,19022.05%148,45815,8046,7846,929
投资性房地产0--0000
固定资产4,890,525-1.82%4,981,3595,274,4785,141,0445,467,060
在建工程309,54811.66%277,214285,310537,80160,125
无形资产236,6823.39%228,912235,835257,986283,073
商誉1,3660.00%1,3661,3661,3661,366
其他非流动资产592,7331.66%583,075596,563237,23244,090
6,212,044-0.13%6,220,3856,409,3566,182,2145,862,642

流动资产
货币资金664,172-9.54%734,2131,088,332760,9361,632,031
应收账款1,148,27811.15%1,033,108939,302748,090877,597
存货1,322,095-11.88%1,500,3081,342,0711,676,4401,383,635
其他流动资产1,056,35412.20%941,466774,520770,969634,494
4,190,900-0.43%4,209,0954,144,2243,956,4354,527,757

流动负债
短期借款760,48235.71%560,353210,153850,682978,831
应付票据0--0150,000293,464110,000
应付帐款695,586-2.10%710,490745,435716,959630,503
其他流动负债175,044-63.03%473,530841,947674,612988,052
1,631,112-6.49%1,744,3731,947,5352,535,7172,707,385
流动资产净值2,559,7873.86%2,464,7222,196,6891,420,7181,820,372
资产总额减流动负债8,771,8311.00%8,685,1078,606,0457,602,9327,683,014

非流动负债
长期借款0--0146,000357,3331,428,000
应付债券0--0000
其他非流动负债553,384-4.14%577,274543,629272,24344,527
553,384-4.14%577,274689,629629,5761,472,527

总权益
    实收股本2,230,0850.00%2,230,0852,227,1602,222,8002,222,800
    储备项目5,963,7051.90%5,852,3825,670,4274,737,6843,981,685
股东权益8,193,7901.38%8,082,4677,897,5876,960,4846,204,485
非控股权益24,657-2.80%25,36618,82912,8726,002